Top Markets
Coin of the day
Petros Pharmaceuticals, Inc. Petros Pharmaceuticals, Inc.

Petros Pharmaceuticals, Inc.

PTPI
Rang in Aktien #40525
Petros Pharmaceuticals, Inc. is a pharmaceutical company dedicated to male... Petros Pharmaceuticals, Inc. is a pharmaceutical company dedicated to male health solutions. Their activities include both the commercialization and ongoing development of Stendra, a prescription PDE-5 inhibitor specifically designed for treating erectile dysfunction (ED). Furthermore, Petros is advancing H100, a proprietary topical formulation currently in development as a potential treatment for acute Peyronie's disease. The company's offerings also extend to a range of erectile dysfunction products, such as vacuum erection devices. Petros Pharmaceuticals, Inc. operates from its base in New York, New York.
Aktienkurs
$0.0034
Marktkapitalisierung
$144.07K
Veränderung (1 Tag)
13.33%
Veränderung (1 Jahr)
-88.67%
Land
US
Handel Petros Pharmaceuticals, Inc. (PTPI)

Kategorie

Kursverlauf für Petros Pharmaceuticals, Inc. (PTPI)
Höchster Schlusskurs: $0.00 am 2026-08-01

Niedrigster Schlusskurs: $940.79 am 2020-12-01
Kursverlauf der Aktie von Petros Pharmaceuticals, Inc. von 2020 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 20.28%
2025 -99.87%
2024 -75.80%
2023 -45.66%
2022 -91.72%
2021 -18.19%
2020 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$171.67 -
DE
$165.47 27.27%
DE
$36.27 22.59%
JP
$232.21 43.17%
CH
$21.32 13.71%
IN